Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Mar 05, 2021

SELL
$80.49 - $108.67 $39,037 - $52,704
-485 Closed
0 $0
Q3 2020

Nov 19, 2020

BUY
$85.91 - $100.83 $41,666 - $48,902
485 New
485 $42,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Catalyst Private Wealth, LLC Portfolio

Follow Catalyst Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalyst Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Catalyst Private Wealth, LLC with notifications on news.